Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Andreas Aspoeck"'
Autor:
Farshad Guirakhoo, Rhonda D. Cardin, David I. Bernstein, Thomas P. Monath, Andreas Aspoeck, Fernando J. Bravo, Klaus Orlinger, Derek A. Pullum, Gerhard Fuhrmann, Elizabeth M. Watson
Publikováno v:
Vaccine. 34:1993-1999
BACKGROUND Congenital cytomegalovirus infection can be life-threatening and often results in significant developmental deficits and/or hearing loss. Thus, there is a critical need for an effective anti-CMV vaccine. OBJECTIVE To determine the efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4fd559f5d94d03fcc560b87ff52431d
https://doi.org/10.1016/j.vaccine.2016.03.005
https://doi.org/10.1016/j.vaccine.2016.03.005
Autor:
Thomas P. Monath, Quazim A. Alayo, Christine A. Bricault, Jessica Jimenez, Daniel D. Pinschewer, Dan H. Barouch, Jennifer L. Shields, Bastien Mangeat, Gerhard Fuhrmann, Klaus Orlinger, Pablo Penaloza MacMaster, Abishek Chandrashekar, Anders Lilja, Matthew Lim, Jade Mondesir, M. Justin Iampietro, Nicholas M. Provine, Crystal Cabral, Andreas Aspoeck, Joseph M Cabral, Michael S. Seaman
Publikováno v:
Vaccine. 35(1)
An important focus in vaccine research is the design of vaccine vectors with low seroprevalence and high immunogenicity. Replication-incompetent lymphocytic choriomeningitis virus (rLCMV) vectors do not elicit vector-neutralizing antibody responses,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa332fd93d7758cb40287ce054905ad4
https://pubmed.ncbi.nlm.nih.gov/27899229
https://pubmed.ncbi.nlm.nih.gov/27899229